Suomen sivusto, jossa voit ostaa halvalla ja laadukas Viagra http://osta-apteekki.com/ toimitus kaikkialle maailmaan.

Erityisesti laatu viagra tästä kaupasta voi taata henkilökohtaisesti viagra Paras laatu kehotan Teitä miellyttää.

Roche.gr

531
Integration of capecitabine (X) into adjuvant therapy comprising

docetaxel (T) followed by 5-FU, epirubicin, and cyclophosphamide
(CEF): Efficacy in patients with triple-negative breast cancer (BC).
H. Joensuu, P. Kel okumpu-Lehtinen, R. Huovinen, A. Jukkola-Vuorinen, M. Tanner, R. Kokko, J. Ahlgren, P. Bono, P. Auvinen, H. Lindman; Helsinki University Central Hospital, Helsinki, Finland; Department of Oncology, Tampere University Hospital, Tampere, Finland; Department of Oncology, Turku University Central Hospital, Turku, Finland; Department of Oncology and Radio therapy, Oulu University Hospital, Oulu, Finland; Kanta-Häme Central Hospital, Hämeenlinna, Finland; Gävle Hospital, Gävle, Sweden; Depart ment of Oncology, Helsinki University Central Hospital, Helsinki, Finland; Department of Oncology, Kuopio University Hospital, Kuopio, Finland; Uppsala University Hospital, Uppsala, Sweden Background: Interim data from this phase III randomized trial (FinXX) evaluating the integration of
capecitabine into anthracycline-/taxane-based adjuvant therapy for early BC were recently published (Lancet Oncol 2009); the present subgroup analysis explores the efficacy results in patients with triple- negative BC.
Methods: 1,500 patients with axillary node-positive or high-risk node-negative (tumor size > 20 mm,
progester one receptor-negative) BC were randomized to the X-containing regimen: 3x XT (X 900 mg/m2 bid d1–14 and T 60 mg/m2 iv d1, q21d) followed by 3x CEX (C 600 mg/m2 iv d1, E 75 mg/m2 iv d1 and X 900 mg/m2 bid d1–14, q21d; n = 753), or the control regimen: 3x T (80 mg/m2 iv d1, q21d) followed by 3x CEF (C 600 mg/m2, E 75 mg/m2 and F 600 mg/m2 all d1, q21d; n = 747) in January 2004 to May 2007. The primary endpoint was recurrence-free survival (RFS) and the median follow-up time 3 yrs.
Results: RFS was significantly increased with the X-containing therapy compared with control (92.5% vs.
88.9%; Cox proportional hazards model hazard ratio [HR] 0.66, 95% CI 0.47–0.94; p = 0.020). Overall, patients without triple-negative disease (n = 1,294) had longer RFS than those with triple-negative cancer (n = 202; HR 0.43, 95% CI 0.29–0.63; p < 0.001). Within the triple-negative BC subgroup, patients in the X arm (n = 93) achieved a longer RFS than those in the control arm (n = 109; HR: 0.43, 95% CI 0.21–0.90; p = 0.024; 3-yr RFS 87.7% vs. 76.6%, respectively), representing a 57% reduction in the risk of breast cancer recurrence or death. RFS of patients with triple-negative BC treated with the X-containing regimen did not differ significantly from RFS of the FinXX study participants whose cancer was not triple negative (HR: 0.74, 95% CI 0.38-1.41; p = 0.357).
Conclusions: In this explorative analysis the integration of X into adjuvant combination chemotherapy
reduced the risk of breast cancer recurrence substantially compared with a control regimen of standard agents in patients with triple-negative early BC. The result needs to be confirmed in studies that address adjuvant X-containing chemotherapy for triple-negative BC.
All content from the American Society of Clinical Oncology Meeting Proceedings, Volume 28, No 15_suppl (May 20), 2010 All content from the American Society of Clinical Oncology Meeting Proceedings, Volume 28, No 15_suppl (May 20), 2010 Copyright American Society of Clinical Oncology 2010, All rights reserved.
Copyright American Society of Clinical Oncology 2010, All rights reserved.

Source: http://www.roche.gr/fmfiles/re711001/Xeloda_Newsletter_Website_Attached_Files/ASCO_ABSTRACTS_531.pdf

curresweb.com

Middle East Journal of Applied Sciences 3(3): 105-112, 2013 ISSN 2077-4613 Soil solarization for controlling soil borne fungi of Tomato ( Lycopersicon esculentum Mill.) plants. 1: Effect of hot water treatment and exposures time on Viability of tomato soil borne pathogenic fungi Riad S.R. El–Mohamedy and Farid Abd- El-Kareem Plant Pathology Department, National Research Cent

cm-porto.pt

C Â M A R A M U N I C I PA L Acta da Reunião Pública da Câmara Municipal do Porto, realizada em 29 de Maio de 2001 PRESENTES: O Senhor Presidente, Eng.º Nuno Magalhães Car- doso, que presidiu, e os Senhores Vereadores Eng.º Orlando BarrosG a s p a r, Prof.ª Ernestina Miranda, Dr.ª Maria José Azevedo, Dr.ª MariaManuela Vieira, Prof. António Hernâni Gonçalves, Dr. José

Copyright © 2010-2014 Medical Pdf Articles